𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Residual pituitary enlargement in primary hypothyroidism despite 1 1/2 years of L-thyroxine therapy

✍ Scribed by Goswami, Ravinder ;Tandon, Nikhil ;Sharma, Raju ;Kochupillai, Narayana


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
88 KB
Volume
43
Category
Article
ISSN
0004-8461

No coin nor oath required. For personal study only.

✦ Synopsis


Pituitary hyperplasia consequent to untreated primary hypothyroidism undergoes impressive regression following thyroxine therapy. We describe a young man with primary hypothyroidism and pituitary hyperplasia, who showed significant but incomplete regression of pituitary enlargement despite 18 months of L‐thyroxine therapy (1 year in replacement dose (150 μg/day) and an additional 6 months in suppressive dose (300 μg/day)).